Drug Shortage Report for SUPREFACT
Report ID | 10149 |
Drug Identification Number | 02225166 |
Brand name | SUPREFACT |
Common or Proper name | Suprefact Inj. M.D. 1mg/ml - vials |
Company Name | CHEPLAPHARM ARZNEIMITTEL GMBH |
Market Status | MARKETED |
Active Ingredient(s) | BUSERELIN |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS |
Packaging size | 2 X 5.5ml |
ATC code | L02AE |
ATC description | HORMONES AND RELATED AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2017-05-15 |
Estimated end date | 2017-06-09 |
Actual end date | 2017-06-05 |
Shortage status | Resolved |
Updated date | 2017-07-06 |
Company comments | Manufacturing Delay |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | ZIEGELHOF 24 GREIFSWALD, MECKLENBURG - WEST POMERANIA GERMANY 17489 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2017-07-06 | English | Compare |
v7 | 2017-06-06 | French | Compare |
v6 | 2017-06-06 | English | Compare |
v5 | 2017-05-16 | English | Compare |
v4 | 2017-05-15 | French | Compare |
v3 | 2017-05-15 | English | Compare |
v2 | 2017-05-12 | French | Compare |
v1 | 2017-05-12 | English | Compare |
Showing 1 to 8 of 8